Christopher White

Christopher White currently serves as the Chief Business Officer at Pykus Therapeutics, following a successful tenure in similar roles at Ocular Therapeutix, Inc. and various other pharmaceutical firms. With extensive experience in business development, corporate strategy, and innovative product planning, Christopher has held key leadership positions at Silver Creek Pharmaceuticals, Sofregen Medical Inc., Entasis Therapeutics, AMAG Pharmaceuticals, Accenture, A.T. Kearney, Arthur D. Little, and Merck. Christopher holds an MBA in Finance from Columbia Business School and a Bachelor of Science in Chemical Engineering from Tufts University.